These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 1989347)

  • 1. Prevention of chronic cyclosporine nephrotoxicity in renal transplantation by picotamide.
    Quarto Di Palo F; Elli A; Rivolta R; Parenti M; Palazzi P; Zanussi C
    Transplant Proc; 1991 Feb; 23(1 Pt 2):969-71. PubMed ID: 1989347
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevention of acute cyclosporine A nephrotoxicity by a thromboxane synthetase inhibitor.
    Smeesters C; Chaland P; Giroux L; Moutquin JM; Etienne P; Douglas F; Corman J; St-Louis G; Daloze P
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):663-9. PubMed ID: 3163209
    [No Abstract]   [Full Text] [Related]  

  • 3. "Cyclosporine-A nephrotoxicity in renal allograft recipients".
    Nix K; Plawecki HM
    J Nephrol Nurs; 1985; 2(5):220-2. PubMed ID: 3903104
    [No Abstract]   [Full Text] [Related]  

  • 4. Evidence against chronic progressive cyclosporine nephrotoxicity.
    Ben-Maimon CS; Burke JF; Besarab A; Jarrell BE; Francos GC; Moyer SS
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1260-2. PubMed ID: 1989206
    [No Abstract]   [Full Text] [Related]  

  • 5. Nephrotoxicity of trimethoprim and cotrimoxazole in renal allograft recipients treated with cyclosporine.
    Thompson JF; Chalmers DH; Hunnisett AG; Wood RF; Morris PJ
    Transplantation; 1983 Aug; 36(2):204-6. PubMed ID: 6349046
    [No Abstract]   [Full Text] [Related]  

  • 6. Is cyclosporine A-induced nephrotoxicity in recipients of renal allografts progressive?
    Thiel G; Mihatsch M; Landmann J; Hermle M; Brunner FP; Harder F
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):169-78. PubMed ID: 3895657
    [No Abstract]   [Full Text] [Related]  

  • 7. Cyclosporine nephrotoxicity and the consequences of conversion to azathioprine.
    Chapman JR; Morris PJ
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):254-60. PubMed ID: 3895664
    [No Abstract]   [Full Text] [Related]  

  • 8. Prevention of cyclosporine-induced nephrotoxicity with transdermal clonidine.
    Luke J; Luke DR; Williams LA; LeMaistre CF; Yau JC
    Clin Pharm; 1990 Jan; 9(1):49-53. PubMed ID: 2302930
    [No Abstract]   [Full Text] [Related]  

  • 9. Cyclosporine chronic nephrotoxicity: histologic follow-up at 6 and 18 months after renal transplantation.
    Savoldi S; Scolari F; Sandrini S; Scaini P; Sacchi G; Tardanico R; Camerini C; Salerni B; Tonini G; De Nobili U
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):777-84. PubMed ID: 3291313
    [No Abstract]   [Full Text] [Related]  

  • 10. Cyclosporine nephrotoxicity in orthotopic liver transplantation.
    Gonwa TA; Poplawski SC; Husberg BS; Nery JR; Klintmalm GB
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):401-4. PubMed ID: 3291276
    [No Abstract]   [Full Text] [Related]  

  • 11. Cyclosporine nephrotoxicity: exploration of the risk factors and prognosis of the renal injury.
    Keown PA; Stiller CR; Wallace AC; McKenzie FN; Wall W
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):247-53. PubMed ID: 3895663
    [No Abstract]   [Full Text] [Related]  

  • 12. Five-year serial renal graft biopsy study in cyclosporine-treated patients.
    Wilczek H; Bohman SO; Klintmalm G; Groth CG
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):812-5. PubMed ID: 3291319
    [No Abstract]   [Full Text] [Related]  

  • 13. Usefulness of fractional excretion of sodium as index of cyclosporine nephrotoxicity in renal transplantation.
    Morales JM; Andres A; Alcazar JM; Prieto C; Diaz de Tueste I; Ruilope LM; Rodicio JL
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):691-9. PubMed ID: 3291305
    [No Abstract]   [Full Text] [Related]  

  • 14. Morphological patterns in cyclosporine-treated renal transplant recipients.
    Mihatsch MJ; Thiel G; Basler V; Ryffel B; Landmann J; von Overbeck J; Zollinger HU
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):101-16. PubMed ID: 3895652
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of cyclosporine in cadaveric renal transplantation in China.
    Xie T; Xu QJ
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):99-101. PubMed ID: 3291336
    [No Abstract]   [Full Text] [Related]  

  • 16. Management and prevention of cyclosporine nephrotoxicity after renal transplantation: use of low doses of cyclosporine, azathioprine, and prednisone.
    Simmons RL; Canafax DM; Strand M; Ascher NL; Payne WD; Sutherland DE; Najarian JS
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):266-75. PubMed ID: 3895665
    [No Abstract]   [Full Text] [Related]  

  • 17. Nephrotoxicity of cyclosporine in autoimmune diseases.
    Hannedouche TP; Delgado AG; Gnionsahe AD; Boitard C; Noël LH; Grünfeld JP
    Adv Nephrol Necker Hosp; 1990; 19():169-85. PubMed ID: 2105578
    [No Abstract]   [Full Text] [Related]  

  • 18. An update on the use of low-dose maintenance cyclosporine A therapy after renal transplantation.
    Karmi SA; DePalma R; Bosch J; Dosa S; Michell A
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):110-3. PubMed ID: 3291218
    [No Abstract]   [Full Text] [Related]  

  • 19. Controlled trial of the protective effect of dihydroergotoxine (Hydergine) on cyclosporine-associated nephrotoxicity in renal graft recipients.
    Vanrenterghem Y; Waer M; De Keyser P; Roels L; Michielsen P
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):615-7. PubMed ID: 3291296
    [No Abstract]   [Full Text] [Related]  

  • 20. A retrospective analysis of late renal graft function: correlation with mean cyclosporine levels and lack of evidence for chronic cyclosporine toxicity.
    Salomon D; Brunson M; Vansickler J; Pfaff W; Howard R; Peterson J; Curry T; Thompson R; Squiers E
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1018-9. PubMed ID: 1989143
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.